- IBDEI2HB ; ; 04-FEB-2020
- ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
- Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
- Q Q
- ;;^UTILITY(U,$J,358.3,39588,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,39588,1,3,0)
- ;;=3^Chronic Lymphocytic Leukemia of B-Cell Type,In Remission
- ;;^UTILITY(U,$J,358.3,39588,1,4,0)
- ;;=4^C91.11
- ;;^UTILITY(U,$J,358.3,39588,2)
- ;;=^5001766
- ;;^UTILITY(U,$J,358.3,39589,0)
- ;;=C91.10^^152^2000^49
- ;;^UTILITY(U,$J,358.3,39589,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,39589,1,3,0)
- ;;=3^Chronic Lymphocytic Leukemia of B-Cell Type,Not in Remission
- ;;^UTILITY(U,$J,358.3,39589,1,4,0)
- ;;=4^C91.10
- ;;^UTILITY(U,$J,358.3,39589,2)
- ;;=^5001765
- ;;^UTILITY(U,$J,358.3,39590,0)
- ;;=C92.11^^152^2000^50
- ;;^UTILITY(U,$J,358.3,39590,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,39590,1,3,0)
- ;;=3^Chronic Myeloid Leukemia,BCR/ABL-Positive,In Remission
- ;;^UTILITY(U,$J,358.3,39590,1,4,0)
- ;;=4^C92.11
- ;;^UTILITY(U,$J,358.3,39590,2)
- ;;=^5001793
- ;;^UTILITY(U,$J,358.3,39591,0)
- ;;=C92.10^^152^2000^51
- ;;^UTILITY(U,$J,358.3,39591,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,39591,1,3,0)
- ;;=3^Chronic Myeloid Leukemia,BCR/ABL-Positive,Not in Remission
- ;;^UTILITY(U,$J,358.3,39591,1,4,0)
- ;;=4^C92.10
- ;;^UTILITY(U,$J,358.3,39591,2)
- ;;=^5001792
- ;;^UTILITY(U,$J,358.3,39592,0)
- ;;=D47.1^^152^2000^52
- ;;^UTILITY(U,$J,358.3,39592,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,39592,1,3,0)
- ;;=3^Chronic Myeloproliferative Disease
- ;;^UTILITY(U,$J,358.3,39592,1,4,0)
- ;;=4^D47.1
- ;;^UTILITY(U,$J,358.3,39592,2)
- ;;=^5002256
- ;;^UTILITY(U,$J,358.3,39593,0)
- ;;=C82.69^^152^2000^53
- ;;^UTILITY(U,$J,358.3,39593,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,39593,1,3,0)
- ;;=3^Cutaneous Follicle Center Lymphoma,Extranodal/Solid Organ Sites
- ;;^UTILITY(U,$J,358.3,39593,1,4,0)
- ;;=4^C82.69
- ;;^UTILITY(U,$J,358.3,39593,2)
- ;;=^5001530
- ;;^UTILITY(U,$J,358.3,39594,0)
- ;;=C82.60^^152^2000^54
- ;;^UTILITY(U,$J,358.3,39594,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,39594,1,3,0)
- ;;=3^Cutaneous Follicle Center Lymphoma,Unspec Site
- ;;^UTILITY(U,$J,358.3,39594,1,4,0)
- ;;=4^C82.60
- ;;^UTILITY(U,$J,358.3,39594,2)
- ;;=^5001521
- ;;^UTILITY(U,$J,358.3,39595,0)
- ;;=D56.2^^152^2000^55
- ;;^UTILITY(U,$J,358.3,39595,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,39595,1,3,0)
- ;;=3^Delta-Beta Thalassemia
- ;;^UTILITY(U,$J,358.3,39595,1,4,0)
- ;;=4^D56.2
- ;;^UTILITY(U,$J,358.3,39595,2)
- ;;=^340496
- ;;^UTILITY(U,$J,358.3,39596,0)
- ;;=D75.9^^152^2000^56
- ;;^UTILITY(U,$J,358.3,39596,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,39596,1,3,0)
- ;;=3^Disease of Blood/Blood-Forming Organs,Unspec
- ;;^UTILITY(U,$J,358.3,39596,1,4,0)
- ;;=4^D75.9
- ;;^UTILITY(U,$J,358.3,39596,2)
- ;;=^5002393
- ;;^UTILITY(U,$J,358.3,39597,0)
- ;;=D59.0^^152^2000^59
- ;;^UTILITY(U,$J,358.3,39597,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,39597,1,3,0)
- ;;=3^Drug-Induced Autoimmune Hemolytic Anemia
- ;;^UTILITY(U,$J,358.3,39597,1,4,0)
- ;;=4^D59.0
- ;;^UTILITY(U,$J,358.3,39597,2)
- ;;=^5002323
- ;;^UTILITY(U,$J,358.3,39598,0)
- ;;=D59.2^^152^2000^60
- ;;^UTILITY(U,$J,358.3,39598,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,39598,1,3,0)
- ;;=3^Drug-Induced Nonautoimmune Hemolytic Anemia
- ;;^UTILITY(U,$J,358.3,39598,1,4,0)
- ;;=4^D59.2
- ;;^UTILITY(U,$J,358.3,39598,2)
- ;;=^5002325
- ;;^UTILITY(U,$J,358.3,39599,0)
- ;;=R59.9^^152^2000^63
- ;;^UTILITY(U,$J,358.3,39599,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,39599,1,3,0)
- ;;=3^Enlarged Lymph Nodes,Unspec
- ;;^UTILITY(U,$J,358.3,39599,1,4,0)
- ;;=4^R59.9
- --- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI2HB 3745 printed Jan 18, 2025@03:29:56 Page 2
- IBDEI2HB ; ; 04-FEB-2020
- +1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
- +2 if 'DIFQR(358.3)
- QUIT
- FOR I=1:2
- SET X=$TEXT(Q+I)
- if X=""
- QUIT
- SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
- SET X=$EXTRACT(X,4,999)
- if $ASCII(Y)=126
- SET I=I+1
- SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
- if $ASCII(Y)=61
- SET Y=$EXTRACT(Y,2,999)
- XECUTE NO
- IF '$TEST
- SET @X=Y
- Q QUIT
- +1 ;;^UTILITY(U,$J,358.3,39588,1,0)
- +2 ;;=^358.31IA^4^2
- +3 ;;^UTILITY(U,$J,358.3,39588,1,3,0)
- +4 ;;=3^Chronic Lymphocytic Leukemia of B-Cell Type,In Remission
- +5 ;;^UTILITY(U,$J,358.3,39588,1,4,0)
- +6 ;;=4^C91.11
- +7 ;;^UTILITY(U,$J,358.3,39588,2)
- +8 ;;=^5001766
- +9 ;;^UTILITY(U,$J,358.3,39589,0)
- +10 ;;=C91.10^^152^2000^49
- +11 ;;^UTILITY(U,$J,358.3,39589,1,0)
- +12 ;;=^358.31IA^4^2
- +13 ;;^UTILITY(U,$J,358.3,39589,1,3,0)
- +14 ;;=3^Chronic Lymphocytic Leukemia of B-Cell Type,Not in Remission
- +15 ;;^UTILITY(U,$J,358.3,39589,1,4,0)
- +16 ;;=4^C91.10
- +17 ;;^UTILITY(U,$J,358.3,39589,2)
- +18 ;;=^5001765
- +19 ;;^UTILITY(U,$J,358.3,39590,0)
- +20 ;;=C92.11^^152^2000^50
- +21 ;;^UTILITY(U,$J,358.3,39590,1,0)
- +22 ;;=^358.31IA^4^2
- +23 ;;^UTILITY(U,$J,358.3,39590,1,3,0)
- +24 ;;=3^Chronic Myeloid Leukemia,BCR/ABL-Positive,In Remission
- +25 ;;^UTILITY(U,$J,358.3,39590,1,4,0)
- +26 ;;=4^C92.11
- +27 ;;^UTILITY(U,$J,358.3,39590,2)
- +28 ;;=^5001793
- +29 ;;^UTILITY(U,$J,358.3,39591,0)
- +30 ;;=C92.10^^152^2000^51
- +31 ;;^UTILITY(U,$J,358.3,39591,1,0)
- +32 ;;=^358.31IA^4^2
- +33 ;;^UTILITY(U,$J,358.3,39591,1,3,0)
- +34 ;;=3^Chronic Myeloid Leukemia,BCR/ABL-Positive,Not in Remission
- +35 ;;^UTILITY(U,$J,358.3,39591,1,4,0)
- +36 ;;=4^C92.10
- +37 ;;^UTILITY(U,$J,358.3,39591,2)
- +38 ;;=^5001792
- +39 ;;^UTILITY(U,$J,358.3,39592,0)
- +40 ;;=D47.1^^152^2000^52
- +41 ;;^UTILITY(U,$J,358.3,39592,1,0)
- +42 ;;=^358.31IA^4^2
- +43 ;;^UTILITY(U,$J,358.3,39592,1,3,0)
- +44 ;;=3^Chronic Myeloproliferative Disease
- +45 ;;^UTILITY(U,$J,358.3,39592,1,4,0)
- +46 ;;=4^D47.1
- +47 ;;^UTILITY(U,$J,358.3,39592,2)
- +48 ;;=^5002256
- +49 ;;^UTILITY(U,$J,358.3,39593,0)
- +50 ;;=C82.69^^152^2000^53
- +51 ;;^UTILITY(U,$J,358.3,39593,1,0)
- +52 ;;=^358.31IA^4^2
- +53 ;;^UTILITY(U,$J,358.3,39593,1,3,0)
- +54 ;;=3^Cutaneous Follicle Center Lymphoma,Extranodal/Solid Organ Sites
- +55 ;;^UTILITY(U,$J,358.3,39593,1,4,0)
- +56 ;;=4^C82.69
- +57 ;;^UTILITY(U,$J,358.3,39593,2)
- +58 ;;=^5001530
- +59 ;;^UTILITY(U,$J,358.3,39594,0)
- +60 ;;=C82.60^^152^2000^54
- +61 ;;^UTILITY(U,$J,358.3,39594,1,0)
- +62 ;;=^358.31IA^4^2
- +63 ;;^UTILITY(U,$J,358.3,39594,1,3,0)
- +64 ;;=3^Cutaneous Follicle Center Lymphoma,Unspec Site
- +65 ;;^UTILITY(U,$J,358.3,39594,1,4,0)
- +66 ;;=4^C82.60
- +67 ;;^UTILITY(U,$J,358.3,39594,2)
- +68 ;;=^5001521
- +69 ;;^UTILITY(U,$J,358.3,39595,0)
- +70 ;;=D56.2^^152^2000^55
- +71 ;;^UTILITY(U,$J,358.3,39595,1,0)
- +72 ;;=^358.31IA^4^2
- +73 ;;^UTILITY(U,$J,358.3,39595,1,3,0)
- +74 ;;=3^Delta-Beta Thalassemia
- +75 ;;^UTILITY(U,$J,358.3,39595,1,4,0)
- +76 ;;=4^D56.2
- +77 ;;^UTILITY(U,$J,358.3,39595,2)
- +78 ;;=^340496
- +79 ;;^UTILITY(U,$J,358.3,39596,0)
- +80 ;;=D75.9^^152^2000^56
- +81 ;;^UTILITY(U,$J,358.3,39596,1,0)
- +82 ;;=^358.31IA^4^2
- +83 ;;^UTILITY(U,$J,358.3,39596,1,3,0)
- +84 ;;=3^Disease of Blood/Blood-Forming Organs,Unspec
- +85 ;;^UTILITY(U,$J,358.3,39596,1,4,0)
- +86 ;;=4^D75.9
- +87 ;;^UTILITY(U,$J,358.3,39596,2)
- +88 ;;=^5002393
- +89 ;;^UTILITY(U,$J,358.3,39597,0)
- +90 ;;=D59.0^^152^2000^59
- +91 ;;^UTILITY(U,$J,358.3,39597,1,0)
- +92 ;;=^358.31IA^4^2
- +93 ;;^UTILITY(U,$J,358.3,39597,1,3,0)
- +94 ;;=3^Drug-Induced Autoimmune Hemolytic Anemia
- +95 ;;^UTILITY(U,$J,358.3,39597,1,4,0)
- +96 ;;=4^D59.0
- +97 ;;^UTILITY(U,$J,358.3,39597,2)
- +98 ;;=^5002323
- +99 ;;^UTILITY(U,$J,358.3,39598,0)
- +100 ;;=D59.2^^152^2000^60
- +101 ;;^UTILITY(U,$J,358.3,39598,1,0)
- +102 ;;=^358.31IA^4^2
- +103 ;;^UTILITY(U,$J,358.3,39598,1,3,0)
- +104 ;;=3^Drug-Induced Nonautoimmune Hemolytic Anemia
- +105 ;;^UTILITY(U,$J,358.3,39598,1,4,0)
- +106 ;;=4^D59.2
- +107 ;;^UTILITY(U,$J,358.3,39598,2)
- +108 ;;=^5002325
- +109 ;;^UTILITY(U,$J,358.3,39599,0)
- +110 ;;=R59.9^^152^2000^63
- +111 ;;^UTILITY(U,$J,358.3,39599,1,0)
- +112 ;;=^358.31IA^4^2
- +113 ;;^UTILITY(U,$J,358.3,39599,1,3,0)
- +114 ;;=3^Enlarged Lymph Nodes,Unspec
- +115 ;;^UTILITY(U,$J,358.3,39599,1,4,0)
- +116 ;;=4^R59.9